Platelet-Rich Plasma Promotes Migration, Proliferation, and the Gene Expression of Scleraxis and Vascular Endothelial Growth Factor in Paratenon-Derived Cells In Vitro
Autor: | Kazuma Miyatake, Yasuteru Yamaguchi, Sosuke Imai, Tomoyuki Saito, Ken Kumagai |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
Vascular Endothelial Growth Factor A platelet-rich plasma (PRP) proliferation Gene Expression Physical Therapy Sports Therapy and Rehabilitation migration Collagen Type I Rats Sprague-Dawley Tendons 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Cell Movement Gene expression medicine Basic Helix-Loop-Helix Transcription Factors Animals paratenon-derived cells (PDCs) Orthopedics and Sports Medicine RNA Messenger Cells Cultured Cell Proliferation 030222 orthopedics business.industry Platelet-Rich Plasma Scleraxis Treatment options Membrane Proteins hemic and immune systems Cell Differentiation 030229 sport sciences differentiation Current Research In vitro Tendon Cell biology Up-Regulation Vascular endothelial growth factor Collagen Type I alpha 1 Chain medicine.anatomical_structure Collagen Type III chemistry tendon proper–derived cells (TDCs) Platelet-rich plasma business |
Zdroj: | Sports Health |
ISSN: | 1941-0921 |
Popis: | Background: Platelet-rich plasma (PRP) is a treatment option for tendon injury because of its effective tendon-healing properties. At the early stage of tendon repair, paratenon-derived cells (PDCs) are thought to play a more important role than tendon proper–derived cells (TDCs). However, there has been no study investigating the effects of PRP on PDCs. Hypothesis: PRP promotes the migration, proliferation, and differentiation of PDCs in vitro. Study Design: Controlled laboratory study. Methods: TDCs and PDCs were isolated from the tendon proper and paratenon of rat Achilles tendons and were cultured to the third passage. PRP was prepared from the rats using the double-spin method. Third-passage TDCs and PDCs were cultured in Dulbecco’s modified Eagle medium with 2% fetal bovine serum (control group) or 2% fetal bovine serum plus 5% PRP (PRP group), and cell migration, proliferation, and differentiation were evaluated. The relative mRNA expression levels of scleraxis (Scx), tenomodulin (Tnmd), collagen type I alpha 1 (Col1a1), collagen type III alpha 1 (Col3a1), and vascular endothelial growth factor A (VEGF) were examined by quantitative real-time reverse transcription polymerase chain reaction. Results: The cell migration rate was significantly higher in the PDCs of the PRP group than in the control group (1.4-fold increase; P = 0.02). Cell proliferation was significantly higher in the PDCs of the PRP group (2.2-fold increase; P < 0.01). In the PDCs, the gene expression levels of Scx, Col1a1, and VEGF were significantly increased by PRP (Scx: 2.0-fold increase, P = 0.01; Col1a1: 5.3-fold increase, P = 0.01; VEGF: 7.8-fold increase, P = 0.01), but the gene expression level of Tnmd, a factor for tendon maturation, was significantly reduced by PRP (0.11-fold decrease; P = 0.02). Conclusion: In vitro PRP promoted migration, proliferation, and tenogenic differentiation with the upregulation of Scx in PDCs. PRP also upregulated the expression of the angiogenic marker VEGF. Clinical Relevance: Our results suggest that PRP treatment in vitro may enhance the tendon-healing properties of PDCs at the initial stage of tendon repair. |
Databáze: | OpenAIRE |
Externí odkaz: |